Nicotine
23
1
3
14
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
4.3%
1 terminated out of 23 trials
93.3%
+6.8% vs benchmark
4%
1 trials in Phase 3/4
50%
7 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (23)
Support Your Heart, Phase 1
Nicotine and Cannabis Vape Labeling Experiment - Spring 2025
The SCAPIS-Snus Study
Pharmacokinetics and Pharmacodynamics of THS With LEVIA Compared to THS With TEREA and to Cigarettes
Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine and Nicotine Analogues
Smoking Harm Reduction Using E-cigarettes and Cytisine
Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking
Nicotine Pharmacokinetics and Pharmacodynamics of Two Variants of VM 1.0 Compared to Cigarettes in Adult Current Smokers
Understanding Vape Marketing Study
Substance Consumption, Personality, and Cognitive Functioning of Chess Players
Developing E-liquid Product Standards (Sweet Spot Study)
Inner Engineering Yoga Program on Short and Long Term Health Effects (ISHA-Impact): A Longitudinal Study
Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouch 1.0 Compared to Velo® Ice Cool and Zyn® Cool Mint Mini Dry in Healthy Smokers
Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes
Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes
Behavioral Pharmacology of Cannabis and Nicotine
Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence
Nicotine and Brain Imaging Research Study
QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt
Nicotinic Modulation of the Default Network